Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-10

Clinical Trial Update: Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating semaglutide for glucose intolerance in women with a prior history of gestational diabetes; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Glucose Intolerance After a Recent History of Gestational Diabetes | Phase 3 | Status: RECRUITING